Build your firm profileApply to be ranked
Law firm
-
United States

Healthcare, pharmaceuticals & biotech

Advising healthcare institutions: corporate, commercial & regulatory

— 2026 —

Leading

King & Spalding

NEW
Jim Boswell | Mark Polston

McDermott Will & Emery

NEW
Eric Zimmerman

Ropes & Gray

NEW
Deborah Gersh | Timothy McCrystal

Excellent

Epstein Becker & Green

NEW
George Breen | Amy Lerman | Mark Lutes | David Matyas

Hogan Lovells

NEW
Lynn Mehler

Latham & Watkins

NEW
Daniel Meron | Scott Shean

Manatt, Phelps & Phillips

NEW
William Bernstein

Highly recommended

Debevoise & Plimpton

NEW
Andrew Bab | Mark Goodman | Maura Monaghan | Paul Rubin

DLA Piper

NEW
Joshua Kaye

Jones Day

NEW
James Dutro

Reed Smith

NEW
Scott Hasselman

Sidley Austin

NEW
Jaime Jones

Recommended

Arent Fox

NEW
Lowell Brown | Stephanie Trunk

Arnold & Porter

NEW
Daniel Kracov | Allison Shuren

Greenberg Traurig

NEW
David Peck | Nancy Taylor

McGuireWoods

NEW
Amber Walsh

Mintz, Levin, Cohn, Ferris, Glovsky And Popeo

NEW
Susan Berson | Karen Lovitch

Morgan, Lewis & Bockius

NEW
Howard Young

Nixon Peabody

NEW
Peter Egan

Norton Rose Fulbright

NEW
Debbi Johnstone

Polsinelli

NEW
Matthew Murer

Sheppard, Mullin, Richter & Hampton

NEW
Eric Klein

In each tier, the firms and people are ordered alphabetically

Build your firm profileApply to be ranked

Research methodology

Our research process spans a four-month period for each ranking cycle. This includes collecting data, which is is a three-month process, and an additional month to process the data and establish the rankings. We rely on four main data sources and various criteria to create or update a ranking.

Consult our methodology